A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program (INGenious)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02297126
Recruitment Status : Completed
First Posted : November 21, 2014
Last Update Posted : July 16, 2018
National Human Genome Research Institute (NHGRI)
Information provided by (Responsible Party):
Todd Skaar, Indiana University